Skip to content
★ Sign in to follow
Max India Limited logo

Max India Limited Stock: price and insider trades · India

IN·Mcap ₹8.7BHealth Care

No insider purchase over the last 90 days. The latest, by Siva Enterprises Private Limited, was filed 07 Sept 2023.

Max India Limited: what insiders have been doing

Max India Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). The past year has been quiet: not a single insider filing for Max India Limited. The previous disclosure was published on 10 June 2024.

Since 2021, the database holds 9 purchases and 14 sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
23
Thresholds
n/a
Buy Volume
€3M
9 ops. · all time
Sell Volume
€3M
14 ops. · all time

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,893 of 26,897 companies
23.0
score / 100
Value
13
Quality
33
FCF yld-17%
Earn yld-14%
EV/EBITDA·
ROE-32%
Gross mgn72%
Net mgn-64%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹154.73
Analyst consensus
·
Income statement
Revenue₹1.9B
Gross profit₹1.4B72% margin
EBITDA-₹820.8M-43% margin
Net income-₹1.2B-55.4% margin
Valuation
P/Book2.0x
Beta0.40
Balance sheet & cash
Market cap₹8.7B
Total debt₹962M
Free Cash Flow-₹1.5B
Debt / Equity24%
Profitability & ownership
ROE-31.8%
ROA-8.8%
% insiders58.4%
% institutions4.1%
Last declaration on 10 June 2024
Declarations23 total
  • ▼
    Executives
    1M INR19SEBI
    4,700 shares@ ₹270.299445.2% of flowEquity SharesSEBI:b1ba43087e5c3cc66bb89badf76119a9eafe0273
  • ▼
    Executives
    7M INR18SEBI
    24,500 shares@ ₹271.4440.4% of flowEquity SharesSEBI:4df9e1887ebb5df09056341f54814ebf9dee7706
  • ▼
    Executives
    2M INR3SEBI
    8,000 shares@ ₹270.5013.2% of flowEquity SharesSEBI:5ff1a34bac62b311c599cd1c767cd80f49b7f38a
  • ▼
    Executives
    2M INR3SEBI
    7,500 shares@ ₹264.6012.1% of flowEquity SharesSEBI:8a2d13ceea770dd634d4b30953b605638e6b9f3a
  • ▼
    Executives
    218,448 INR2SEBI
    800 shares@ ₹273.061.3% of flowEquity SharesSEBI:3dd4fcc6d7b434c137fcc202a1b233eaee650410
  • ▼
    Executives
    1M INR3SEBI
    5,200 shares@ ₹271.40158.6% of flowEquity SharesSEBI:1801411cdbc3cb0971379061f5a0f4c8b381005a
  • ▼
    Executives
    443,994 INR14SEBI
    2,000 shares@ ₹221.9972.7% of flowEquity SharesSEBI:1af989e1c325b9b705485e5110ea07ec30dc1278
  • ▼
    Executives
    299,822 INR15SEBI
    1,350 shares@ ₹222.090410.6% of flowEquity SharesSEBI:3f5c88abb2560202d2cc79e505f4add402293e98
  • ▼
    Executives
    863,160 INR15SEBI
    4,000 shares@ ₹215.795.2% of flowEquity SharesSEBI:8d59d78132c1facdc572cae2c2a654bbc24aa64a
  • ▼
    Executives
    1M INR18SEBI
    5,850 shares@ ₹211.793244.2% of flowEquity SharesSEBI:8e89dd2da23a14b5b37e8c4600716ff44b3c37ad
  • ▼
    Executives
    1M INR3SEBI
    6,000 shares@ ₹201.0127.4% of flowEquity SharesSEBI:b18f8fdfe374b9d8f6de9f5ac747b8db069fbe4f
  • ▼
    Executives
    1M INR3SEBI
    9,330 shares@ ₹155.10019.0% of flowEquity SharesSEBI:b4a05e2ef089135bd4912688baf98f24c2a07058
  • ▼
    Executives
    50M INR10SEBI
    323,000 shares@ ₹154.303100.0% of flowEquity SharesSEBI:92249ebe61841568b9afef7d3730d93f06d2b758
  • ▲
    Related company / holdingExecutives
    50M INR4SEBI
    323,000 shares@ ₹154.331320.7% of flowEquity SharesSEBI:7c91dae4e76b15bf9b819a70219112baca2c793b
    Canonical exit: 5 Dec 2023 (T+90)
  • ▲
    Executives
    0SEBI
    0Equity SharesSEBI:528c060a8a9f04649d373d178bb2bfffcc56073c
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Executives
    0SEBI
    0Equity SharesSEBI:40f6be480e22731f6e522302d763d1fc6841e613
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Executives
    0SEBI
    0Equity SharesSEBI:1d09f4aa2bde7574dc865f6679565211711a653a
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Executives
    0SEBI
    0Equity SharesSEBI:8c4613740170a3ac8b9317182a6752b980abc46c
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    0SEBI
    0Equity SharesSEBI:cafcae899c84e2a68d46ec69e3d13ab55b5559ae
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Related company / holdingExecutives
    0SEBI
    0Equity SharesSEBI:1a7b833916b9decade883c43369555f801498a01
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Executives
    0SEBI
    0Equity SharesSEBI:e95f17f5f1d013e004a03b1ca3cdc449b7466c18
    Canonical exit: 27 Nov 2022 (T+90)
  • ▼
    Related company / holdingExecutives
    189M INR10SEBI
    2,683,900 shares@ ₹70.402.63% mcap100.0% of flowEquity SharesSEBI:bfc6d2309ec22140548bd1756a4b1ec40ec0bf4d
  • ▲
    Related company / holdingExecutives
    189M INR10SEBI
    2,683,900 shares@ ₹70.505679.3% of flowEquity SharesSEBI:617f866a8d144664299156e0decd8001fa448eee
    Canonical exit: 26 Sept 2021 (T+90)

23 of 23 declarations

About Max India Limited

Max India Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the Bombay Stock Exchange.